Skip to main content
SpringerLink
Log in

Axicabtagene-ciloleucel

Immune effector cell-associated neurotoxicity syndrome

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Scott BJ, et al. Long-Term Cognitive and Neuropsychiatric Outcomes in Adults Who Have Received Chimeric Antigen Receptor T-Cell (CAR-T) Therapy for Aggressive Lymphoma at Stanford - a Pilot Feasibility Study. Blood 140 (Suppl. 1): 5201-5202, Nov 2022. Available from: URL: https://dx.doi.org/10.1182/blood-2022-168229 [abstract]

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Axicabtagene-ciloleucel. Reactions Weekly 1987, 47 (2023). https://doi.org/10.1007/s40278-023-51791-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-51791-5

Search

Navigation